SUMMARY
Cullin-Ring E3 Ligases (CRLs) regulate a multitude of cellular pathways through specific substrate receptors. The COP9 signalosome (CSN) deactivates CRLs by removing NEDD8 (N8) from activated Cullins. The structure of stable CSN-CRL can be used to understand this mechanism of regulation. Here we present the first structures of the neddylated and deneddylated CSN-CRL2 complexes by combining single particle cryo-electron microscopy (cryo-EM) with chemical cross-linking mass spectrometry (MS). These structures reveal a conserved mechanism of CSN activation, consisting of conformational clamping of the CRL2 substrate by CSN2/CSN4, release of the catalytic CSN5/CSN6 heterodimer and finally activation of the CSN5 deneddylation machinery. Using hydrogen deuterium exchange-MS we show that CRL2 binding and conformational activation of CSN5/CSN6 occur in a neddylation-independent manner. The presence of NEDD8 is required to activate the CSN5 active site. Overall, by synergising cryo-EM with MS, we identified novel sensory regions of the CSN that mediate its stepwise activation mechanism and provide a framework for better understanding the regulatory mechanism of other Cullin family members.
(designated as CSN1-8 by decreasing molecular weights of 57-22 kDa), and is organized in a "splayed hand" architecture, which has high sequence and structural homology to the proteasome lid 13, 14, [16] [17] [18] . CSN1, 2, 3, 4, 7 and 8 are structurally homologous to each other and together contribute to the fingers of the "splayed hand" which arise from extended N-terminal α-helical repeats 16, 18 . CSN5 and 6 are also closely related structurally and form a globular heterodimer located on the palm of the hand. CSN5 is responsible for the deneddylase activity of the CSN. A ninth subunit, CSNAP, has recently been identified, and is thought to play a role in stabilising the CSN complex 18 .
Electron microscopy (EM) based structural analysis has provided important insights into the mechanism of CRL1 regulation by CSN 16, 19 . CRL4A and CRL3 have also been observed to form such complexes 20 . However, despite intense interest, structural information of the CSN bound to CRLs remains limited to CRL1 12, 16, 19 , CRL4A 20 , and a low-resolution map of a dimeric CSN-CRL3-N8 20 complex. In particular the analysis of the CSN-CRL4A complex 20 identified at least three major steps by which CRL~N8 is deneddylated by the CSN. In the first step, the extended N-terminal helical modules of CSN2 and CSN4 conformationally "clamp" the C-terminal domain of the CRL4A~N8
and RBX1 16, 19, 20 . The second step involves the release and consequent relocation of CSN5/CSN6 closer to NEDD8, brought about by disruption of the CSN4/CSN6 interface 20 . Disrupting the binding interface between CSN4/CSN6 through removal of the CSN6 insertion-2 loop (Ins-2), resulted in enhanced deneddylase activity 13 , presumably due to more complete release of CSN5/CSN6. In the final step, the mobile CSN5 binds to NEDD8, leading to deneddylation via its JAB1/MPN/MOV34 (JAMM) metalloprotease domain 21 . The JAMM motif consists of H138, H140 and D151 zinc-coordinating residues, and residue E104 of the CSN5 insertion-1 loop (Ins-1) 13 . In apo-CSN, the Ins-1 loop occludes the CSN5 active site, auto-inhibiting the deneddylase 13, 22 . Deneddylation is also severely diminished by a H138A point mutation in CSN5 13 .
Surprisingly, the CSN can also form complexes with each of the Cullin 1-5 family members even without NEDD8 23 . Free CRLs such as CRL1 have been reported to readily bind and inhibit the CSN, albeit at relatively lower affinity than the neddylated CRL1 24 . While the exact role of CSN-CRL complexes remains unclear, it has been hypothesised that these complexes may function to regulate the cellular level of ubiquitin ligase activity of CRLs once they have been deneddylated, effectively sequestering E3 ligases from the intracellular environment 24 .
Building on the existing knowledge of the CSN-CRL systems, here we pose the question: are similar structural changes to be found in other CSN-CRL complexes, and how does binding of neddylated CRLs lead to activation of the CSN5 catalytic site? To address this, here, we present novel structures of the CSN-CRL2~N8 complex, together with the first structure of the CSN-CRL2 deneddylation product. We complemented our cryo-EM analysis with chemical cross-linking mass spectrometry (XL-MS) allowing us to clarify the positions of particularly dynamic regions in the complexes. We used hydrogen-deuterium exchange mass spectrometry (HDX-MS) to interrogate the role of the CSN4/CSN6 interface in communicating CRL binding to the CSN5 active site. Overall, our structures of the CSN-CRL2~N8 and its deneddylation product, the CSN-CRL2, provide a molecular level understanding of how deneddylation is performed by the CSN.
RESULTS

Cryo-EM structures of the CSN-CRL2~N8 complex
To study the molecular interactions between neddylated CRL2 (CRL2~N8) and the CSN, we performed single-particle cryo-EM to resolve a structure of the assembled CSN-CRL2~N8 (referred to as the holocomplex) ( Fig. S1-S2 ). The mutation H138A in the catalytic site of CSN5 subunit makes it possible to assemble CSN-CRL2~N8 complexes in which NEDD8 remains covalently attached over the time scale for experimentation 16, 19 . This mutant form of CSN was used throughout the work described below, unless otherwise specified.
Using three-dimensional classification, we were able to generate maps of three different structures: a) a holocomplex map at 8.2 Å, b) a map of the complex with little or no density for VHL at 8.0 Å, and c) a map of the complex with little or no density for CSN5/CSN6/VHL at 6.5 Å (Fig. S2, Fig. S3 ). The two partial complexes likely arise from compositional heterogeneity in the original samples from which the structural analysis has succeeded in isolating subpopulations.
Next, we fitted into each map, the crystallographic CSN (PDB 4D10) and a homology model of the CRL2 (including the VHL-ELOB-ELOC) using molecular dynamics flexible fitting 25 ( Table 1 ; Methods). In the model of the holocomplex (8.2 Å), the main interactions occur between the C-terminal end of Cullin-2 and the extended N-terminal helical repeats of CSN2 and CSN4 (Fig. 1a-b) . Compared to their apo-CSN crystal structure conformations (PDB 4D10), CSN2 and CSN4 are moved by 30 and 51 Å, respectively, towards Cullin-2 ( Fig. S4a) . In each case, the motion is a swinging rotation about hinges located close to the CSN2 and CSN4 winged helix domains: in the case of CSN2 this is coupled with an additional rotation about the axis of the superhelix formed from its N-terminal helical repeats. In the case of CSN4 the movement is coupled to the detachment of CSN4 from the Ins-2 loop of CSN6 by ~30
Å and leads to a ~12 Å shift in CSN5 (Fig. 1c, Fig. S4b ). Only minor conformational changes were found in the CSN1, CSN3, CSN7B or CSN8 subunits. In the CRL2~N8 moiety, a number of relatively small rearrangements of Cullin-2, RBX1, ELOB, ELOC and VHL subunits were observed compared to its crystal structure 26 ( Fig. S4c-d ).
In our EM maps and the other published CSN-CRL structures 16, 19, 20 , the exact position of NEDD8 and the Cullin-2 Winged-Helix B (WHB) domain were difficult to determine.
To address this limitation, we carried out XL-MS experiments on the CSN-CRL2~N8 complex using the bis(sulfosuccinimidyl)suberate (BS3) cross-linker which targets lysine sidechains (Methods). We identified a total of 24 inter-and 60 intra-protein cross-links (Table S1 , Fig. S5a-b) . To generate a model of the CSN-CRL2~N8, we performed cross-link guided modelling which allows the placement of the WHB, NEDD8 and VHL subunits using identified cross-links from XL-MS (Methods). We imposed a cross-link distance threshold of 35 Å which takes into account the length of two lysine side chains (15 Å), the BS3 cross-linker length (10 Å) and an extra 10 Å to allow for domain-level flexibility (Methods). Our model of the CSN-CRL2~N8 satisfies all cross-link distances (Fig. S5c) (Fig. 1d, Fig. S5d , green text). In this conformation, the isopeptide bond of NEDD8 is juxtaposed towards to the CSN5 active site. For the isopeptide bond of NEDD8 to reach the CSN5 active site, the Cullin-2 WHB domain must be extended from its crystallographic conformation towards the CSN5 by 19 Å (Fig. S5e) . 
Structure of the deneddylated CSN-CRL2 complex
Having determined the structure of the CSN-CRL2~N8 complex, we next sought to detail any conformational differences in the deneddylated CSN-CRL2. The affinity of CSN for the non-neddylated CRLs is significantly lower than for the neddylated forms, limiting the yield of the desired product 19 . We used native MS experiments to confirm the formation of the complex (Fig. S6) . We next resolved a cryo-EM map of the CSN-CRL2 to 8.8 Å resolution (Fig. S7) . Although the resolution of the CSN-CRL2 map is similar to that for CSN-CRL2~N8 holocomplex, we only observed partial density for VHL and CSN4. This is most likely due to the reduced stability of the CSN-CRL2
assembly in the absence of NEDD8. We were however able to use the density obtained to model the CSN-CRL2 structure, which has principally the same topology as the neddylated holocomplex (Fig. 2a) . Using the same procedure as for the neddylated CSN-CRL2~N8 complex, we fitted CSN and CRL2 subunits into the density map of the CSN-CRL2 complex (Methods). We then utilised cross-link guided modelling to establish the position of the WHB which lacked clear density, similar to the neddylated holocomplex ( Fig. S8 ; Methods). To determine any local changes across the CSN-CRL2~N8 in the absence of NEDD8, we aligned the cryo-EM models of neddylated and deneddylated holocomplexes using the C-terminal helical bundle as a reference point (Fig. S9) . We systematically compared the conformations of each subunit ( Fig. S9b-i ). Compared to its structure in the CSN-CRL2~N8, the N-terminal helices of CSN2 are shifted by ~21 Å towards the Cullin-2 C-terminal domain (Fig. 2b, Fig. S9c ). This change in CSN2 in the absence of NEDD8, leads to a structural difference in Cullin-2 which rotates upwards towards the rest of the CSN by 20 Å (Fig. 2c, Fig. S9a ). The position adopted by Cullin-2 in the deneddylated holocomplex, places ELOB closer to CSN1, forming a CSN1-ELOB interface (Fig. 2d) . Interactions between substrate adaptor complex and CSN1
have similarly been reported for the CSN-CRL1~N8 16 and CSN-CRL4A~N8 20 . RBX1
remains clamped between CSN2 and CSN4 (Fig. 2e) .
The most striking conformational differences were observed in CSN6 (Fig. 2f, Fig.   S9g ). In the absence of NEDD8, CSN6 is dramatically shifted away from its position in the neddylated holocomplex by ~40 Å (Fig. 2f) . This previously unknown conformation of CSN6 appears to be unique, differing from the conformation captured in our neddylated holocomplex, and the CSN-CRL4A~N8 and CSN-CRL3~N8 19 structures. Similar to the neddylated holocomplex, no significant changes were identified in CSN3, CSN7B and CSN8 subunits. Overall, comparison between the CSN-CRL2~N8 and CSN-CRL2 structure reveal significant conformational rearrangements in CSN5/CSN6 and the N-terminal domain of CSN2. 
HDX-MS reveals a stepwise mechanism of CSN activation
Having determined the structures of the neddylated and deneddylated CSN-CRL2 complexes, we set off to characterise the local dynamics using HDX- Fig. 3b; Fig. S12a-b) . These observations are in line with the conformational clamping by CSN2/CSN4 onto the C-terminal of CRL2 as seen in the cryo-EM structures of neddylated and deneddylated complexes. Within CSN2 of both experiments, we observed significantly destabilised regions around helical modules 6-9. These observations likely identify the hinge points which permit the bending of CSN2 to clamp onto the Cullin-2 C-terminus ( Fig. 3b; Fig. S12a-b) . Colour scheme follows that of (b).
Conformational remodelling of the CSN5 active site is achieved in the presence of NEDD8
We next considered the release mechanism of the CSN5/CSN6 subunits of both the neddylated and deneddylated holocomplexes. In both Δ(CSN-CRL2~N8 -CSN) and Δ(CSN WT -CRL2 -CSN WT ) experiments, the Ins-2 loop of CSN6 was destabilised, correlating with the release of CSN6 from its interface with CSN4 and in line with the allosteric activation mechanism of CSN by CRL4A 19 ( Fig. 4a-b i ). An interesting difference between the neddylated and deneddylated complexes is that the CSN6 α4
helix is destabilised only in the absence of NEDD8 (Fig. 4b i) . Similarly, the CSN5 α7 helix is also destabilised in both neddylated and deneddylated conditions (Fig. 4a-b ii). The CSN6 α4 and CSN α7 helices are topologically knotted in the CSN5/CSN6
heterodimer and tether the globular domains of CSN5/CSN6 to the C-terminal helical bundle 13 . These observations suggest that structural changes are required in the helical knot to bring about release of the CSN5/CSN6 globular domains from their apo conformation.
Another finding is that we identified destabilisation in the Ins-2 loop of CSN5 (Fig. 4a-b ii). The Ins-2 loop of CSN5 has a lesser understood role in CSN activation. In isolated CSN5, the Ins-2 loop is highly disordered 22 ( Fig. S13a) , while it folds into a helical-loop structure when incorporated into the CSN 13 ( Fig. S13b) . Accompanying the changes in the CSN5 Ins-2 loop, in both comparative HDX-MS experiments, we detected destabilisation of the α5 helix area which surrounds the CSN5 active site (Fig. 4a-b ii) . The changes in both the CSN5 Ins-2 and α5 helix indicate a major conformational remodelling in the area adjacent to the CSN5 active site, which can be triggered through the binding of both CRL2 or CRL2~N8 to the CSN in a NEDD8-independent manner. It is only in the presence of NEDD8, that the CSN5 active site is further destabilised suggesting that in a final activation step, NEDD8 induces conformational changes in the active site itself (Fig. 4a-b iii, Fig. S14 ). 
DISCUSSION
Here we have combined EM and MS analyses to provide new insights into the mediation of CRL2 by the CSN. We have described the first structures of CSN-CRL2~N8 and a novel deneddylated CSN-CRL2 structure. As far as we are aware, this is also the first structural description of a non-neddylated CSN-CRL complex.
Furthermore, we combined cryo-EM maps with comparative HDX-MS to expand on the stepwise activation mechanism of the CSN, involving a conformational network of both NEDD8-independent and dependent stages. We suggest that the steps which lead to deneddylation are mostly NEDD8-independent, except for the remodelling of the CSN5 active site which requires NEDD8 to encounter the CSN5 active site.
Our map of the deneddylated CSN-CRL2 holocomplex represents a complex in which the CSN is still associated with its CRL2 reaction product. Resolving this structure has provided several important details into how activation of the CSN is achieved. Our comparison of the neddylated and deneddylated holocomplex structures indicated that the CSN2 contacts the CRL2 C-terminal domain in a slightly different conformation to when the CRL2 is modified with NEDD8. Between both neddylated and deneddylated conformations, the clamping by CSN2 involves destabilisation of the CSN2 helical modules 6-9 which function possibly as a hinge that allows the CSN2 to bend upwards towards the CRL2. The plasticity of these N-terminal helices presumably permits the binding of deneddylated and alternative Cullin isoforms. HDX-MS further indicates that RBX1 and CSN4 form an interface, which is more prominent in the absence of NEDD8, as shown through stabilisation of the two interfaces (Fig. S12b) . Overall, the conformational variations seen in the CSN2 N-terminal helical modules (Fig. 2b) , the bend of CRL2 (Fig. 2c) and the HDX differences in CSN4/RBX1 (Fig. S12b) may therefore be attributable to the seemingly promiscuous affinity that allows CSN2 to bind to each of the different Cullins regardless of neddylation.
We uncovered structural and dynamical aspects of both the neddylated and deneddylated CSN-CRL2 complexes. Beginning our interpretation from valuable studies of the CSN-CRL1~N8 and CSN-CRL4A~N8 systems, we have identified several major conformational switches of the CSN which must be activated by the CRL2 substrate to bring about deneddylation. While some of these steps are conserved ubiquitously among other CSN-CRL complexes (e.g. CSN2/CSN4
clamping in CSN-CRL1~N8 and CSN-CRL4A~N8), our study has identified additional steps for the CRL2-bound CSN complex, enabling the most complete mechanistic interpretation of CSN activation by a CRL to date (Fig. 5) . In the first activation step, the CSN and CRL2~N8 associate through major conformational changes in CSN2 and CSN4, which clamp onto the CRL2 (Fig. 5a-b) . The dramatic change in CSN4 breaks its interface with CSN6 through the CSN6 Ins-2 loop and releases the CSN5/CSN6
heterodimer (Fig. 5c) . The release of CSN5/CSN6 appear consistent with the destabilised knotted helices of CSN6 that our HDX has identified. It is plausible that these two helices function as the mechanical hinges which allow the CSN5/CSN6 to be released from their auto-inhibited conformations but remain tethered to the rest of the CSN. Although the resolution presented by CSN5 in our cryo-EM structures prevents us from making molecular level observations, our HDX data can provide local detail for the CSN5 active site. The release of CSN5/CSN6 is accompanied by HDX changes in areas surrounding the CSN5 active site, including the CSN5 Ins-2 loop.
Up to here, the changes experienced by the CSN can be brought about in a NEDD8-independent manner. In the next stage, the presence of NEDD8 acts as a selectivity filter which results in remodelling of the CSN5 active site itself (Fig. 5d) . These changes presumably expose the CSN5 JAMM ligands of the metalloprotease site and allow subsequent deneddylation to occur (Fig. 5e) . Finally, deneddylation ensues with the cleavage of NEDD8 from CRL2 and the dissociation of the complex (Fig. 5f) . The fact that CSN can then re-associate with its CRL2 reaction product following dissociation, as shown by our study and structure of the CSN-CRL2, suggests that this complex may serve a lesser understood role in the CSN-CRL network. Furthermore, there may be additional roles for the CSN as suggested by the compositional plasticity seen in our CSN-CRL2~N8 classes. In our map of the CSN-CRL2~N8, the Cullin arm was observed to shift downwards away from CSN3 in maps deficient of the VHL substrate receptor (Fig. S15) , consistent with the coupling of VHL binding to a conformational change in the rest of the CRL2 portion of the protein. This type of behaviour may allow the CRL2 to adapt to individual substrates and substrate receptors which vary in size and geometry as has been suggested with the CRL4A system 20 . Additionally, it may reflect changes associated with remodelling of the CRL2
by the dissociation of the VHL and the binding of alternative substrate receptors. In future work we will seek to determine whether the CSN can mediate substrate receptor dissociation.
Overall, our study has provided unprecedented level of detail at the role of CRL2 and NEDD8 on regulating the activation mechanism of CSN. We have revealed that the series of mechanistic responses of the CSN that lead up to deneddylation, can be triggered even by the CRL2 reaction product in a completely NEDD8-independent manner. The presence of NEDD8 on the activated CRL2 substrate, triggers remodelling within the catalytic site of the CSN5 subunit during the final stage of CSN activation. We envision that our results will have implications for the entire family of CRL proteins and their regulatory relationship with the CSN. Our study therefore provides a template not only for assisting investigations of other CRL-based systems but also for bringing together data from different structural biology techniques that otherwise will be reported independently.
METHODS AND MATERIALS Preparation and expression of bacmids
WT and catalytically reduced CSN 5H138A bacmids were a kind gift from Radoslav Enchev (The Francis Crick Institute, London) 19 . pcDNA3-myc3-CUL2 was a gift from Yue Xiong (Addgene plasmid #19892 33 ). HA-VHL wt-pBabe-puro was a gift from
William Kaelin (Addgene plasmid #19234 34 ). RBX1, ELOB and ELOC were cloned from cDNA from the Mammalian Gene Collection (MGC) purchased from Dharmacon.
To improve protein yield, an N-terminally truncated (1-53) natural isoform of VHL was also produced for use with mass spectrometry. Both isoforms of VHL were sub-cloned into a pET-52b(+) vector (Novagen) to add an N-terminal
Step-Tag II. Genes were assembled into pACEBac1 using I-CeuI/BstXI restriction sites via the MultiBac system 35 . RBXI and CUL2 were assembled into one vector and ELOB, Strep II-VHL(ΔN) and ELOC into a second vector. Correct assembly was confirmed by sequencing of entire genes. DH10EmBacY cells were transformed with each assembly and blue/white selection was performed on L-agar plates containing 50 μg/ml kanamycin, 7 μg/ml gentamycin, 10 μg/ml tetracyclin, 100 μg/ml Bluo-Gal (Thermo Scientific) and 40 mg/ml IPTG. DH10MultiBac bacmid DNA was isolated from single white colonies. Recombinant baculoviruses were generated in Sf9 cells using standard amplification procedures.
Expression and Purification of Recombinant CRL2
High 
In vitro Neddylation of CRL2
APPBP1-Uba3, UbcH12 and Nedd8-His were purchased from (Enzo Life Sciences).
The neddylation reaction was carried out for 10 mins at 37 o C with 8 μM CRL2, 350 nM APPBP1-Uba3, 1.8 μM UbcH12 and 50 μM Nedd8 in a reaction buffer (50 mM HEPES pH7.5, 150 mM NaCl) supplemented with 1.25 mM ATP and 10 mM MgCl2. The reaction was quenched with 15 mM DTT and ice prior to loading onto a 1 ml StrepTrap HP column (GE Healthcare). CRL2~N8 was eluted with reaction buffer supplemented with 2.5 mM desthiobiotin and neddylation was confirmed by SDS-PAGE.
Expression and Purification of Recombinant CSN
High Five Cells were co-infected with the bacmids gifted by Radoslav Enchev (The Francis Crick Institute, London) and protein was expressed as described for CRL2, with an additional Ni-affinity step prior to gel filtration to exploit the His6-tag on the CSN5 subunit. For Strep-affinity chromatography 50 mM HEPES pH7.5, 200 mM NaCl, 2 mM TCEP, 4% glycerol buffer was used, with the addition of 2.5 mM ddesthiobiotin for elution. For Ni-affinity using 2x HisTrap HP columns (GE Healthcare) in tandem, the same buffer was used, but protein was eluted by a 0-300 mM Imidazole gradient across 45 ml. For size exclusion chromatography using a Superdex200 16/600 (GE Healthcare) column was equilibrated with 50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM TCEP, 2% glycerol. A second size exclusion step using a Superose 6 10/300 GL column equilibrated in 15 mM HEPES pH 7.5, 150 mM NaCl, 1 mM DTT, 1% glycerol.
Cryo-EM of CSN-CRL2~N8
The CSN-CRL2~N8 complex was formed by incubation between CRL2~N8 (1.1x molar excess) and CSN at room temperature for 90 min. The preparation (~0.5 MDa)
was subjected to size exclusion chromatography using a Superose 6 Increase 3.2/300 column (GE Healthcare), equilibrated in 15 mM HEPES pH 7.5, 100 mM NaCl, 0.5 mM DTT, 1% glycerol to reduce the contribution of apo components. Fractions from the leading edge of the peak were buffer exchanged into 15 mM HEPES pH 7.5, 100
mM NaCl using PD SpinTrap G-25 columns (GE Healthcare) before initial assessment by negative stain EM. Cryo grids were prepared using a Vitrobot (FEI).
A cryo-EM dataset was collected beamline M02 from Quantifoil grids with an extra carbon layer at the Electron Bio-Imaging Centre (eBIC -Diamond Light Source, UK) on a Titan Krios 300 kV with Gatan K2 detector (M02), Å/pix = 1.06. Movies of 25 frames (dose = 1.85 e/Å 2 ) were motion corrected in RELION 2.0 36 using MOTIONCOR2 37 and subsequent CTF estimation of micrographs was performed using CTFFIND4 38 (Fig. S1) . Auto-picking selected ~317,000 particles from ~3100 micrographs. Particles were subjected to reference free 2D classification to assess data quality and to remove contaminants selected by auto-picking. This process reduced the particle number to ~250,000. Following particle selection through 2D classification, particles were divided into 15 3D classes. Three of these classes (~69,000 particles) were selected for further classification and processing, as described in Fig. S2 .
Cryo-EM of CSN-CRL2
The CSN-CRL2 complex was formed by incubation between CRL2 (1.1x molar excess) and CSN at room temperature for 90 min. Samples were loaded onto a 5-50%
glycerol GraFix gradient containing 0-0.2% glutaraldehyde and ultracentrifuged for 24 hours at 4˚C. Gradients were manually fractionated and the resultant aliquots assessed by SDS-PAGE to determine the extent of cross-linking. Fractions were also assessed using negative stain EM in-house. In order to reduce the glycerol content of samples for cryo-EM, fractions containing the desired complex (as determined by negative stain EM) were pooled together and gel filtered into 15 mM HEPES pH 7.5, 100 mM NaCl, 0.5 mM using a Superose 6 Increase 10/300 GL column (GE Healthcare). Fractions were again assessed by negative stain before preparing cryogrids using a Vitrobot (FEI). A cryo-EM dataset was collected at the Electron BioImaging Centre (eBIC -Diamond Light Source, UK) on a Titan Krios 300 kV with Gatan K2 detector (M02), with a sampling of 1.047 Å/pix. Movies of 85 frames (dose = 1.0 e/Å 2 ) were motion corrected in RELION 3.0 39 using MOTIONCOR2 37 and subsequent CTF estimation of micrographs was performed using CTFFIND4 38 . Auto-picking selected ~309,000 particles from ~6800 micrographs. Particles were subjected to reference free 2D classification to assess data quality and to remove contaminants selected by auto-picking. This process reduced the particle number to ~208,000.
Following particle selection through 2D classification, particles were divided into 6 3D classes first with alignment, then subsequently without alignment with a mask around CSN5/CSN6 in order to perform focused classification on this area. The map that showed the greatest recovery of detail for CSN5/CSN6 (Fig. S7) was then subjected
to 3D auto refinement and post-processing. Local resolution was estimates using ResMap 40 as part of the RELION wrapper.
Homology modelling of the CRL2
Homology modelling of the CRL2 was necessary, due to a combination of missing domain structure for the Cullin-2 Winged-Helix A (WHA) and VHL subunit in the only crystal structure of CRL2 (PDB 5N4W). Homology modelling was performed through two stages: first, generating a CRL2 structure with a correct WHA domain, and second, generating the complete CRL2 intact with the VHL-ELOB-ELOC adaptor complex. In the first stage, we performed structural alignment of the CRL2 (5N4W) and CRL1
(1LDJ) structures in PyMOL. Using MODELLER 41 , a single model of the CRL2 was generated using the slow molecular refinement option of MODELLER. The model was manually evaluated for correct fold, including the correct positioning of residues (such as the Cullin-2 K689 NEDD8-acceptor site) already present in the 5N4W crystal structure. In the second stage, we aligned the CRL2 model with the VHL-ELOB-ELOCCullin-2 fragment (4WQO) to generate a template for homology modelling. The isoform 3 of VHL (missing residues 1-53) was used for modelling to maintain consistency with the experimental construct. Again, a single model of the CRL2 (with VHL/ELOB/ELOC) was generated using the slow molecular refinement option of MODELLER. The final model of the CRL2 shows a root mean squared deviation (RMSD) of 3.6 Å when compared to the initial crystal structure (5N4W) but includes a complete WHA domain and VHL subunit.
Model fitting of EM maps
All models were fitted using CSN subunits sourced from the 4D10 crystal structure (chains A-H) and the CRL2 (VHL-ELOB-ELOC) structure generated and described in 44 . MDFF was performed in two steps: an initial energy minimisation step (scaling factor = 0.3 for 50,000 steps) which coerced each subunit into their map densities, and a second equilibration run (scaling factor = 10 for 200,000 steps) which applied molecular dynamics to produce structurally and energetically realistic structures. Secondary structure, cis-peptide and chirality characteristics of the initial models were calculated and enforced throughout each step to avoid a loss of internal structure for each subunit. For each of the CSN-CRL2~N8
and CSN-CRL2 structures, subunits/domains which lacked clear density were not included to avoid interference with the fitting of other subunits. These were the WHB domain (Cullin-2 residues 656-745) for all maps, NEDD8 in all NEDD8-including maps, and VHL in the CSN-CRL2 map. The cross-correlation coefficient (CCC) which calculates the degree of overlap between the cryo-EM map and a simulated map of the same resolution from the atomic model, are reported for each model in Table 1 of the manuscript.
Native mass spectrometry
All spectral data were collected using a SYNAPT G2-Si (Waters Corp., Manchester, UK) high-definition mass spectrometer and samples were ionized using a NanoLockSpray™ dual electrospray inlet source (Waters Corporation). Protein samples were buffer exchanged and de-salted using Mini Bio-Spin Chromatography
Columns (Bio-Rad) into pH 7.5 150 mM ammonium acetate. Native MS measurements were made at 20˚C with trap collision-energy between 25-75 V.
Hydrogen deuterium exchange mass spectrometry
Hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments were recommended by the manufacturer and a blank run using the pepsin wash was performed between each sample to prevent significant peptide carry-over from the pepsin column. Optimized peptide identification and peptide coverage for all samples was performed from undeuterated controls (three-four replicates). All deuterium timepoints were performed in triplicate. Sequence identification was made from MS E data from the undeuterated samples using the Waters ProteinLynx Global Server 2.5.1
(PLGS). The output peptides were filtered using DynamX (v. 3.0) using the following filtering parameters: minimum intensity of 2500, minimum and maximum peptide sequence length of 5 and 30 respectively, minimum MS/MS products of 3, minimum products per amino acid of 0.1, and a minimum peptide score of 5. Additionally, all the spectra were visually examined and only those with high signal to noise ratios were used for HDX-MS analysis. The amount of relative deuterium uptake for each peptide was determined using DynamX (v. 3.0) and are not corrected for back exchange.
Confidence intervals for the ΔHDX of any individual timepoint were then determined according to Houde et al 45 . Specifically, the 98% confidence intervals for the ΔHDX at any single timepoint were calculated per protein per timepoint.
Chemical cross-linking mass spectrometry
20 μl of approximately 20 μM CRL2~N8 were incubated with 1-5 mM bis(sulfosuccinimidyl)suberate (BS3) cross-linker for 1 hr at 25°C and 350 rpm in a thermomixer. After cross-linking, proteins were (i) separated by gel electrophoresis (NuPAGE) followed by in-gel digestion or (ii) digested in solution and generated peptides were pre-fractionated by gel filtration. Gel electrophoresis was performed using the NuPAGE system according to manufacturer's protocols. In-gel digestion was performed as described before 46 . 47 .
Data analysis for XL-MS
Raw files were converted into Mascot generic format (mgf) files using pXtract (http://pfind.ict.ac.cn/software/pXtract/index.html). Mgf's were searched against a reduced database containing CSN and CRL2 proteins 48 . Search parameters were: instrument spectra, HCD; enzyme, trypsin; max missed cleavage sites, 3; variable modifications, oxidation (methionine) and carbamidomethylation (cysteine); crosslinker, BS3; min peptide length, 4; max peptide length, 100; min peptide mass, 400
Da; max peptide mass, 10,000 Da; False Discovery Rate, 1%. Potential cross-linked di-peptides was evaluated by their spectral quality. Circular network plots were generated using XVis 49 .
XL-MS guided placement of the WHB, NEDD8 and VHL subunits
Cross-links determined from XL-MS for the CSN-CRL2~N8 and CSN-CRL2 complexes were used to clarify the position of the WHB, NEDD8 and VHL subunits which lacked clear density in our cryo-EM maps. We performed XL-guided placement using the Integrative Modelling Platform (IMP) 50 , using as input, the map-fitted models of the CSN-CRL2~N8 and CSN-CRL2. The CSN-CRL2~N8 model post-map fitting, included all subunits except the WHB and NEDD8. Similarly, the CSN-CRL2 model included all subunits except the WHB and VHL. Separately, the subunits of each complex were initialized as coarse-grained bead models, representing each residue as a single bead. The WHB domain (Cullin-2 residues 656-745) and VHL was sourced from the homology model of the CRL2 (detailed in the section 'Homology Modelling of the CRL2'). NEDD8 was sourced from the crystal structure of neddylated CRL5 (3DQV). WHB, NEDD8 and VHL were set as mobile rigid bodies, while all other subunits were kept stationary.
Our modelling procedure utilized two types of cross-links. The first type are pseudocross-links which maintain the correct topology of the complex: a single pseudo-crosslink between Cullin-2 T655 to WHB T656 of 5 Å to mimic a covalent bond, and connections between VHL-ELOB, VHL-ELOC and VHL-Cullin-2 to maintain integrity of the VHL-ELOB-ELOC adaptor complex and its interface with Cullin-2. A single pseudo-crosslink of 10 Å was used to mimic the isopeptide bond of WHB K689~N 8 G76 (7.5 Å lysine side chain + ~3 Å glycine C-terminus). The second type are cross-links determined experimentally between WHB, NEDD8 and VHL with its surrounding subunits ( Table   S1- Table S1 for the CSN-CRL2~N8 and Table S2 CSN-CRL2. Additionally see Fig. S5 and S8.
